Second Quarter 2026 Results: Gross Margin of 90.9% and Category Leadership HERZLIYA, Israel and CALGARY, Alberta, Aug. 31, 2026 /PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (OTCQB: INNPF) ("Innocan" or the "Company"), today reported today 2026 financial consolidated results for...
Hence then, the article about innocan pharma announces second quarter fiscal year 2026 results with revenue of us 5 25m cad 7 3m was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Innocan Pharma Announces Second Quarter Fiscal year 2026 Results, With Revenue of US$5.25M (CAD 7.3M) )
Also on site :
- TrustNordisk Unveils Fresh Deals & Teaser-Trailer For Venice Contender ‘Woman Unknown’
- 1986 ‘Talk Dirty to Me,’ Recorded by Poison in Just 12 Days for $23,000 and Called a ‘Glorified Demo,’ Hit the Top 10 and Never Left
- US threatens Iran with ‘financial violence’